• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Robot Surgeons, GSK Shingles Vaccine, Uninsurance Rate

By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
Down Arrow Button Icon
October 23, 2017, 1:06 PM ET

Happy Monday, Dailies. Popular Science is out with its 30th annual list of “The 100 Greatest Innovations” of the year—and the top dozen are in the category of health. The list includes some well-covered breakthroughs, such as targeted killer T cells in cancer immunotherapy and the gene-editing DIY’er CRISPR, which I’ve written about here and here. But among the litany of stand-out innovations are some novel and little-known inventions—devices, moreover, that set out to solve a problem that either no one had set out to solve before or that no one had been able to solve until now.

One of those is the Aeroform Tissue Expander System. Here’s how PopSci writers Claire Maldarelli and Chelsea Harvey describe it:

“When a woman undergoes breast reconstruction, surgeons stretch the existing tissue by injecting saline into implanted bladders—a painful process that demands doctor visits, needles, and analgesics. The Aeroform lets women control the process at their own, more-tolerable pace. Patients use a wireless controller to signal a CO2 cartridge to release air that stretches a silicone implant, bit by bit.”

I’ll take PopSci’s word for it that it works as promised, but the idea itself is brilliant: a personalized approach to healing designed to replace a “one-size-fits-all” solution that never was.

Also on the list is a smart glove that helps stroke victims recover hand movement and agility, a lightweight wearable that makes it easier for those with epilepsy to monitor night seizures, and a cordless breast-milk pump “that’s quiet enough for a woman to use while on a conference call,” the authors write.

The commonality to all of the above? User-centrism. These products are designed to help make a process (stroke rehab, seizure monitoring, breast milk pumping) easier for consumers and patients, not the myriad other players in the health system (physicians, hospitals, insurers). If the digital health revolution can keep moving the dial toward that notion, the dividends for all of us will be profound.

One more great story to highlight: Today, Fortune published online a fascinating read about Intuitive Surgical, a robotic surgery pioneer that, as we said, is turning “medical sci-fi into reality.” Intuitive Surgical is one of the innovative companies featured on Fortune’s brand new “Future 50” list, which we developed with consulting firm BCG and which analyzes companies’ DNA, so to speak—their cultures, investments, patents, workforces, and other internal metrics—to find those that are poised for explosive growth in the coming months and years.

As with so many other companies on the list, Intuitive Surgical’s secret sauce is an intrinsic drive to continually reinvent itself as it reinvents the tools of surgery. And the author of this feature—Brainstorm Health Daily’s very own Sy Mukherjee—did a terrific job of capturing that essence.

It’s a must-read.

With that, here’s the rest of the day’s news from Sy.

Clifton Leaf, Editor in Chief, FORTUNE
@CliftonLeaf
clifton.leaf@fortune.com

DIGITAL HEALTH

Coming to an O.R. near you: The robot surgeon. As Cliff so kindly mentioned above, I had an opportunity to explore the corporate DNA—and impressive, pioneering technology—at the heart of Intuitive Surgical, the company that's long been dominating the robotic-assisted surgery space. One major question I set out to answer is: How does Intuitive keep the progress going after being the market leader for so long, especially as competitors are expected to enter the scene? (Fortune)

INDICATIONS

GlaxoSmithKline wins FDA approval of next-gen shingles vaccine. British pharma giant GlaxoSmithKline (GSK) has won a critical Food and Drug Administration (FDA) approval for Shingrix, a new and improved version of the shingles vaccine. This is a particularly important approval since shingles is one of the few conditions that everyone over a certain age is recommended to get, leading analysts to estimate sales could exceed $1.3 billion per year by 2023. (Reuters)

THE BIG PICTURE

Uninsured rate ticks upward for first time since 2014 amid Obamacare chaos. Gallup finds that the U.S. uninsurance rate rose to 12.3% in the third quarter of 2017—a 1.4 percentage point rise since the end of 2016 and the first significant increase in the rate of uninsured Americans since Obamacare's coverage expansion and requirement to carry insurance took effect in 2014. In real numbers, this suggests about 3.5 million more Americans who are now uninsured as uncertainty continues to swirl around the health law (and cuts to outreach and other Affordable Care Act funding instituted by the Trump administration). (Gallup)

REQUIRED READING

The Wolf of Wall Street Thinks Some ICOs Are the 'Biggest Scam Ever', by David Meyer

Delta Says Hello to Apple, by Barb Darrow

London's New Tax on Older, More Polluting Cars Starts Today, by Lucinda Shen

California Courts May Consider Legalizing Prostitution, by Chris Morris

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortune newsletters.
About the Authors
By Sy Mukherjee
See full bioRight Arrow Button Icon
By Clifton Leaf
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

boomer
CommentaryLongevity
America is not ready for its own longevity crisis — and 2026 is the wake-up call
By Aimee DeCamillo and Diane TyApril 12, 2026
10 hours ago
dalmation
AIHealth
Man’s best friend may soon live a little longer thanks to a new pill promising to extend your pup’s lifespan
By Catherina GioinoApril 11, 2026
1 day ago
AI promises to free workers from grunt work, but psychologists say those mindless tasks are exactly what our brains need to recover
AIworker productivity
AI promises to free workers from grunt work, but psychologists say those mindless tasks are exactly what our brains need to recover
By Marco Quiroz-GutierrezApril 11, 2026
2 days ago
Alpha Brain Review
HealthDietary Supplements
Alpha Brain Review (2026): Expert Reviewed Nootropic
By Emily PharesApril 10, 2026
2 days ago
The 5 Best Weight Loss Pills of 2026: Expert and Doctor Approved
HealthDietary Supplements
The 5 Best Weight Loss Pills of 2026: Expert and Doctor Approved
By Emily PharesApril 10, 2026
2 days ago
Ritual Synbiotic+ Probiotic Review (2026): An Expert’s Opinion
HealthDietary Supplements
Ritual Synbiotic+ Probiotic Review (2026): An Expert’s Opinion
By Christina SnyderApril 10, 2026
2 days ago

Most Popular

'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuz
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuz
By Fortune EditorsApril 11, 2026
21 hours ago
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational training
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational training
By Fortune EditorsApril 11, 2026
1 day ago
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Belt
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Belt
By Fortune EditorsApril 11, 2026
2 days ago
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’
By Fortune EditorsApril 12, 2026
8 hours ago
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loans
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loans
By Fortune EditorsApril 12, 2026
12 hours ago
Navy tests Hormuz blockade as expert says U.S. military prepares for round 2 and could degrade Iran's hold over the strait to a 'manageable level'
Politics
Navy tests Hormuz blockade as expert says U.S. military prepares for round 2 and could degrade Iran's hold over the strait to a 'manageable level'
By Fortune EditorsApril 11, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.